CSL staff.
William West | AFP | Getty Photos
Shares of Australian biotech agency CSL plunged 17% Wednesday after it introduced that Chief Govt Officer Paul McKenzie will step down, and posted weak earnings for the primary half of the 12 months.
Former senior govt Gordon Naylor will function interim CEO till a everlasting substitute is discovered.
That is breaking information. Please examine again for updates.
Source link
#Shares #Australian #biotech #main #CSL #plunge #CEO #departure #weak #earnings
